2.5 Colonization, Infection, Contamination, & Pseudo-Infection

CBIC Associate Infection Prevention and Control a-IPC

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Introduction & Exam Overview

1.1 About the CBIC a-IPC Certification 1.2 Exam Format, Scoring, & Logistics 1.3 Effective Study Strategies & Preparation Plan

2 Chapter 2: Processes to Identify Infectious Diseases

2.1 Chain of Infection & Pathogen Characteristics 2.2 Diagnostic & Laboratory Testing in IPC 2.3 Identifying Healthcare-Associated Infection Syndromes 2.4 Specimen Collection, Handling, Storage, & Transport 2.5 Colonization, Infection, Contamination, & Pseudo-Infection 2.6 Prophylactic, Empiric, & Therapeutic Antimicrobial Use 2.7 Host Risk Factors & Emerging Infectious Disease Threats

3 Chapter 3: Surveillance and Epidemiologic Investigation

3.1 Surveillance Methods & Program Design 3.2 Epidemiological Calculations & Rate Metrics 3.3 Outbreak Investigation Protocols & Epidemic Curves 3.4 NHSN Definitions & Standardized Infection Ratios (SIR) 3.5 Descriptive Statistics & Presenting Surveillance Data 3.6 Surveillance Across the Care Continuum 3.7 Notifiable Disease Reporting, Data Sources, & Registries 3.8 Data Validation & Surveillance Program Evaluation 3.9 Outbreak Control Measures, Environmental Sampling, & Reporting

4 Chapter 4: Preventing and Controlling Transmission

4.1 Standard Precautions & Hand Hygiene Guidelines 4.2 Transmission-Based Precautions & Isolation Protocols 4.3 PPE Selection, Donning, Doffing, & Safety 4.4 Safe Injection Practices & Medication Preparation 4.5 Patient-Care Equipment & Point-of-Care Device Handling 4.6 Emergency Preparedness & the Infection Preventionist's Disaster Role 4.7 Bioterrorism, Special Pathogens, & Community Response Planning

5 Chapter 5: Environment of Care

5.1 Environmental Cleaning & Surface Disinfection 5.2 Water Utilities, Air Handling, & Building Systems 5.3 Construction, Renovation, & Infection Control Risk Assessment (ICRA) 5.4 Laundry, Linen, Waste Management, & Food Safety 5.5 Product Recalls, Supply Chain Monitoring, & Device Incident Reporting

6 Chapter 6: Cleaning, Disinfection, and Sterilization of Medical Devices

6.1 Spaulding Classification System 6.2 Reprocessing Steps & High-Level Disinfection (HLD) 6.3 Sterilization Methods, Monitoring, & Quality Assurance 6.4 Single-Use Devices, Outsourced Reprocessing, & IFU Review 6.5 Reprocessing Failure Investigation & Patient Notification

7 Chapter 7: Employee and Occupational Health

7.1 Occupational Exposures & Post-Exposure Prophylaxis 7.2 Healthcare Personnel Immunizations & Screening 7.3 Work Restrictions & Fit-for-Duty Evaluations 7.4 Sharps Injury Prevention, Product Sensitivities, & Alternatives

8 Chapter 8: Management, Communication, and Antimicrobial Stewardship

8.1 IPC Program Governance, Policies, & Accreditation 8.2 Interdisciplinary Collaboration & Crisis Communication 8.3 Antimicrobial Stewardship Principles & Interventions 8.4 Chain of Command, Resource Advocacy, & the Business Case

9 Chapter 9: Education, Research, and Performance Improvement

9.1 Adult Learning Principles & Staff Education 9.2 Quality Improvement Models & Implementation Science 9.3 Critical Appraisal of Infection Prevention Literature

2.5 Colonization, Infection, Contamination, & Pseudo-Infection

Key Takeaways Explain This Topic AI

Colonization means an organism is present and multiplying without provoking a host immune response or clinical illness; infection requires tissue invasion plus a host response.

Contamination describes organisms introduced onto a specimen or surface from an external source, such as coagulase-negative staphylococci recovered from only one of two blood culture sets.

Pseudo-infection is a positive laboratory result in a patient with no clinical disease, usually from reagent, equipment, or processing contamination; a cluster of pseudo-infections is a pseudo-outbreak.

Asymptomatic bacteriuria is colonization and should not be treated except in pregnancy or before invasive urologic procedures, making it the classic distractor in CAUTI questions.

Distinguishing these four states protects surveillance accuracy, prevents unnecessary antimicrobial therapy, and avoids isolating patients who do not need it.

Last updated: August 2026

2.5 Colonization, Infection, Contamination, & Pseudo-Infection

Quick Answer: Colonization = organism present and replicating, no host response . Infection = invasion plus host response (fever, leukocytosis, local inflammation, tissue damage). Contamination = organism introduced from outside the patient during collection or processing. Pseudo-infection = a positive result in a patient with no disease , caused by laboratory or equipment contamination.

A positive culture is a fact. What that fact means is an interpretation, and the a-IPC blueprint lists differentiating these states as an explicit task. Getting it wrong is expensive in both directions: treating colonization wastes antimicrobials and selects for resistance, while dismissing true infection as contamination delays care.

The Four States Side by Side

State Organism present? Multiplying in host? Host response? Clinical illness? Typical response
Colonization Yes Yes No No No antimicrobials; contact precautions only if the organism warrants it
Infection Yes Yes Yes Yes Treat; counts for surveillance if criteria met
Contamination Yes (on the specimen) No No No Recollect; do not treat

Pseudo-infection Reported, but not truly from the patient No No No Investigate the laboratory or device, not the patient

Colonization

Colonization is the normal state of the human body. Skin, gut, oropharynx, and vagina carry dense microbial populations continuously. In healthcare, the term usually refers to carriage of an epidemiologically significant organism without disease:

MRSA in the anterior nares
VRE in the gastrointestinal tract
Carbapenem-resistant Enterobacterales (CRE) in stool

Candida auris on the skin, axilla, and groin — notable because it colonizes persistently for months and sheds heavily into the environment

Clostridioides difficile in the colon of a patient with formed stool

Colonized patients matter enormously to IPC even though they are not sick. They are reservoirs : they seed the environment, transfer organisms to staff hands, and can later become infected themselves when a device or surgical breach gives the organism a portal of entry. This is why active surveillance cultures, contact precautions, and decolonization protocols (nasal mupirocin plus chlorhexidine bathing for MRSA; universal chlorhexidine bathing in some ICUs) exist. It is also why a colonized patient does not get antibiotics.

Infection

Infection requires the organism to invade tissue and the host to respond. Evidence includes:

Systemic signs: fever >38°C or hypothermia <36°C, leukocytosis or leukopenia, tachycardia, hypotension
Local signs: erythema, warmth, swelling, purulent drainage, pain, loss of function

Laboratory and imaging support: elevated inflammatory markers, a new infiltrate on chest radiograph, purulence on Gram stain

Histopathology: tissue invasion on biopsy — the definitive discriminator

Exam Tip: In immunocompromised or elderly patients the host response can be blunted or atypical. An afebrile nursing-home resident with new confusion and hypothermia may be septic. Absence of fever does not equal absence of infection.

Contamination

Contamination is organism introduction during collection or processing , not from the patient's tissue. The canonical example is a blood culture growing coagulase-negative staphylococci in one of two sets drawn from separate sites, in a patient with no line, no fever, and no clinical deterioration. Skin flora were carried into the bottle at venipuncture.

Discriminators favouring contamination:

Organism is typical skin flora — coagulase-negative staphylococci, Corynebacterium , Cutibacterium acnes , Bacillus species (non-anthracis), viridans streptococci in some contexts

Only one of multiple sets is positive
Long time-to-positivity (often >48 hours)
Multiple organism types in a single bottle
No clinical picture consistent with bacteremia

NHSN addresses this explicitly: for common commensal organisms, the bloodstream infection definition requires two or more blood cultures drawn on separate occasions plus signs and symptoms, precisely so that single contaminated bottles do not become reportable CLABSIs.

Pseudo-Infection and Pseudo-Outbreaks

A pseudo-infection is a positive laboratory result in a patient who genuinely has no infection at that site, arising somewhere in the specimen-to-report pathway rather than in the patient. Sources include:

Contaminated equipment — automated endoscope reprocessors, bronchoscopes rinsed with tap water, blood gas analyzers

Contaminated reagents, media, collection tubes, or water baths
Cross-contamination during laboratory processing

Assay change — introducing a more sensitive molecular platform can raise "positives" overnight with no change in disease

Surveillance artifact — a new case-finding method detecting cases that were always there

When several occur together, you have a pseudo-outbreak . The signature is a cluster of positive cultures without clinical illness : several bronchoalveolar lavage specimens growing Mycobacterium abscessus in patients who are afebrile, breathing comfortably, and radiographically clear.

Why the distinction changes the investigation

In a true outbreak you look for a transmission pathway among patients. In a pseudo-outbreak you look at the device, the reagent, the water, or the laboratory bench . Chasing patients in a pseudo-outbreak wastes weeks and can lead to unnecessary treatment, unnecessary isolation, and reputational harm.

The Highest-Yield Application: Asymptomatic Bacteriuria

Asymptomatic bacteriuria (ASB) is bacteriuria without urinary symptoms — colonization, not infection. It is extremely common in catheterized patients, where bacteriuria becomes near-universal after about 30 days of catheterization.

Do not screen for it and do not treat it, with two exceptions: pregnancy and before invasive urologic procedures with anticipated mucosal bleeding.

Treating ASB does not reduce catheter-associated urinary tract infection (CAUTI); it drives C. difficile infection and resistance.

The corresponding diagnostic stewardship control is to stop reflexively culturing urine in patients without urinary symptoms, and to use reflex culture only when urinalysis suggests pyuria.

A parallel exists for C. difficile : do not test formed stool . Nucleic acid amplification testing detects the toxin gene in colonized patients, so testing a patient with formed stool or a patient on laxatives converts colonization into a reportable, treated "infection" that was never there.